Tamoxifen treatment causes early hepatic insulin resistance.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 4, p. 495, doi. 10.1007/s00592-019-01468-6
- By:
- Publication type:
- Article
Works matching IS 09405429 AND DT 2020 AND VI 57 AND IP 4
Results: 16
1
2
1,5-Anhydroglucitol × glycated hemoglobin A1c/100 as a potential biomarker for islet β-cell function among patients with type 2 diabetes.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 4, p. 439, doi. 10.1007/s00592-019-01452-0
- By:
- Publication type:
- Article
3
Selecting the optimal risk threshold of diabetes risk scores to identify high-risk individuals for diabetes prevention: a cost-effectiveness analysis.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 4, p. 447, doi. 10.1007/s00592-019-01451-1
- By:
- Publication type:
- Article
4
Improved metabolic control using glucose monitoring systems leads to improvement in vibration perception thresholds in type 1 diabetes patients.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 4, p. 433, doi. 10.1007/s00592-019-01450-2
- By:
- Publication type:
- Article
5
Cardiorespiratory fitness and right ventricular mechanics in uncomplicated diabetic patients: Is there any relationship?
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 4, p. 425, doi. 10.1007/s00592-019-01449-9
- By:
- Publication type:
- Article
6
Comparison of expression profiling of circular RNAs in vitreous humour between diabetic retinopathy and non-diabetes mellitus patients.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 4, p. 479, doi. 10.1007/s00592-019-01448-w
- By:
- Publication type:
- Article
7
"Out of the box" solution for skin problems due to glucose-monitoring technology in youth with type 1 diabetes: real-life experience with fluticasone spray.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 4, p. 419, doi. 10.1007/s00592-019-01446-y
- By:
- Publication type:
- Article
8
Incretin-based therapy and risk of cholangiocarcinoma: a nested case–control study in a population of subjects with type 2 diabetes.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 4, p. 401, doi. 10.1007/s00592-019-01444-0
- By:
- Publication type:
- Article
9
The clinical significance of long non-coding RNA ANRIL level in diabetic retinopathy.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 4, p. 409, doi. 10.1007/s00592-019-01442-2
- By:
- Publication type:
- Article
10
Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 4, p. 469, doi. 10.1007/s00592-019-01439-x
- By:
- Publication type:
- Article
11
Platelet aggregation is not altered among men with diabetes mellitus.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 4, p. 389, doi. 10.1007/s00592-019-01438-y
- By:
- Publication type:
- Article
12
Diabetic ketoacidosis in acromegaly: a case study—somatostatin analogs adverse event or disease complication?
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 4, p. 491, doi. 10.1007/s00592-019-01437-z
- By:
- Publication type:
- Article
13
Modulation of gut microbiota contributes to effects of intensive insulin therapy on intestinal morphological alteration in high-fat-diet-treated mice.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 4, p. 455, doi. 10.1007/s00592-019-01436-0
- By:
- Publication type:
- Article
14
Potential explanation for the association between hemoglobin A1c level and subsequent malignancy development.
- Published in:
- 2020
- By:
- Publication type:
- Letter
15
Erythrocyte lifespan as a proposed explanation for increased risk of malignancies among people with low HbA1c.
- Published in:
- 2020
- By:
- Publication type:
- Letter
16
On the dynamics of the human endocrine pancreas and potential consequences for the development of type 1 diabetes.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 4, p. 503, doi. 10.1007/s00592-019-01420-8
- By:
- Publication type:
- Article